Tribinoid 5%CBD + 5%CBG + 5%CBN

1,299.00

Tribinoid is a product composed of three different cannabinoids:

The cannabinoid cannabidiol (CBD) has been shown to have analgesic, anticonvulsant, muscle relaxant, anxiolytic, neuroprotective, antioxidant, and antipsychotic activity. This wide range of effects is likely due to its complex pharmacological mechanisms. In addition to binding to the CB1 and CB2 receptors of the endocannabinoid system, there is evidence that CBD activates serotonergic 5-HT1A and vanilloid TRPV1-2 receptors, antagonizes alpha-1 adrenergic and µ-opioid receptors, inhibits synaptosomal uptake of noradrenaline, dopamine, serotonin, and gamma-aminobutyric acid, and cellular uptake of anandamide.

The cannabinoid cannabigerol (CBG) Cannabigerol is under laboratory research to determine its pharmacological properties and potential effects in disease conditions. Unlike the main psychoactive cannabinoid THC, cannabigerol antagonizes CB1 receptors and is both an alpha2-adrenoceptor agonist and a mild 5HT1A receptor antagonist. Cannabigerol shows binding affinity for CB1 and CB2 and has been evaluated in laboratory models of colitis. It has antibacterial properties.

The cannabinoid cannabinol (CBN)The positive effects of CBN have also been shown in relation to immune system regulation. One of the most frequently cited studies of CBN compares the effects of this cannabinoid to pharmaceutical sedatives such as diazepam. This opinion was reached by researchers from the SteepHill laboratory during tests on mouse subjects: “Consuming a dose of 2.5 to 5 milligrams of CBN provides a sedative and body-relaxing effect equal to a dose of 5 to 10 milligrams of the pharmaceutical sedative diazepam.”

The effect is active for 5 to 6 hours.”

Certificate:
(0 customer reviews)

Out of stock

For purchases over 2000, free shipping

  • 30 day easy returns
  • Order yours by 2.30pm for same day dispatch
Guaranteed safe checkout

Tribinoid is a product composed of three different cannabinoids.

The cannabinoid cannabidiol (CBD)

Cannabidiol (CBD) is a phytocannabinoid discovered in the 1940s. It is one of 113 identified cannabinoids in cannabis plants, along with tetrahydrocannabinol (THC), and makes up to 40% of the plant’s extract.

Although the exact mechanism and extent of the effects of THC and CBD are not fully understood, CBD has been shown to have analgesic, anticonvulsant, muscle relaxant, anxiolytic, neuroprotective, antioxidant, and antipsychotic activity. This wide range of effects is likely due to its complex pharmacological mechanisms. In addition to binding to CB1 and CB2 receptors of the endocannabinoid system, there is evidence that CBD activates serotonergic 5-HT1A and vanilloid TRPV1-2 receptors, antagonizes alpha-1 adrenergic and µ-opioid receptors, inhibits synaptosomal uptake of noradrenaline, dopamine, serotonin and gamma-aminobutyric acid, and cellular uptake of anandamide, acts on mitochondria, stores Ca2, blocks low-voltage (T-type) activated Ca2 channels, stimulates inhibitory glycine receptor activity, and inhibits amide hydrolase (FAAH) activity [ A31555, A31574].
Cannabidiol is a phytocannabinoid derived from Cannabis species that has no psychoactive activity, analgesic, anti-inflammatory, antineoplastic and chemopreventive effects. Once administered, cannabidiol (CBD) exerts its antiproliferative, antiangiogenic and pro-apoptotic activity through a variety of mechanisms that are unlikely to involve cannabinoid receptor 1 (CB1), CB2 or vanilloid receptor 1 signalling. CBD stimulates endoplasmic reticulum (ER) stress and inhibits AKT/mTOR signaling, thereby activating autophagy and promoting apoptosis. In addition, CBD increases the production of reactive oxygen species (ROS), which further increases apoptosis. This agent also increases the expression of intercellular adhesion molecule 1 (ICAM-1) and tissue inhibitor of matrix metalloproteinases-1 (TIMP1) and decreases the expression of inhibitor of DNA binding 1 (ID-1). It inhibits invasiveness and metastasis of cancer cells. CBD can also activate transient receptor potential vanilloid type 2 (TRPV2), which can enhance the uptake of various cytotoxic agents in cancer cells. The analgesic effect of CBD is mediated by the binding of this agent to and activation of CB1.

Source:

https://en.wikipedia.org/wiki/Cannabidiol

https://pubchem.ncbi.nlm.nih.gov/compound/644019

The cannabinoid cannabigerol (CBG)

Cannabigerol (CBG) is one of more than 120 identified cannabinoid compounds found in the Cannabis plant genus. Cannabigerol is the decarboxylated form of cannabigerol acid, the parent molecule from which other cannabinoids are synthesised. Cannabigerol is a minor constituent of cannabis. During plant growth, most of the cannabigerol is converted to other cannabinoids, primarily tetrahydrocannabinol (THC) or cannabidiol (CBD), leaving about 1% of the cannabigerol in the plant.

Cannabigerol is under laboratory research to determine its pharmacological properties and potential effects in disease conditions. Unlike the main psychoactive cannabinoid THC, cannabigerol antagonizes CB1 receptors and is both an alpha2-adrenoceptor agonist and a mild 5HT1A receptor antagonist. Cannabigerol shows binding affinity for CB1 and CB2 and has been evaluated in laboratory models of colitis. It has antibacterial properties.

Source:

https://en.wikipedia.org/wiki/Cannabigerol

https://pubchem.ncbi.nlm.nih.gov/compound/5315659

The cannabinoid cannabinol (CBN)

Cannabinol – CBN is a substance from the class of cannabinoids contained in plants of the genus Cannabis.It is a metabolite of tetrahydrocannabinol (THC), i.e. it is formed by the gradual degradation of THC in the presence of oxygen. It acts as a weak agonist at CB1 CB2 cannabinoid receptors with a lower affinity compared to THC. The psychoactive effects are similar to those of THC, but a several times larger dose is needed to achieve them.

Cannabinol is a cannabinoid isolated from the Cannabis plant, which is a metabolite of tetrahydrocannabinol (THC) and has potential immunosuppressive and anti-inflammatory effects. Cannabinol preferentially binds to the G-protein coupled cannabinoid receptor CB2, which is mainly expressed on various immune cells such as T-cells, B-cells, macrophages and dendritic cells. Stimulation of CB2 receptors by cannabinol can induce apoptosis in these cells and inhibit the production of various cytokines. Cannabinol shows minimal affinity for CB1 and has a weak effect on the central nervous system.

Source:

https://cs.wikipedia.org/wiki/Kanabinol

https://pubchem.ncbi.nlm.nih.gov/compound/2543

Additional information

Weight 50 g
Dimensions 3 × 3 × 9 cm

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.